Dow Today: E.I. Du Pont De Nemours & Company (DD) Lower

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

The Dow Jones Industrial Average ( ^DJI) is trading up 24 points (+0.1%) at 16,448 as of Thursday, Apr 17, 2014, 1:36 p.m. ET. During this time, 261.2 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 422.9 million. The NYSE advances/declines ratio sits at 1,693 issues advancing vs. 1,271 declining with 195 unchanged.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Holding back the Dow today is E.I. du Pont de Nemours & Company (NYSE: DD), which is lagging the broader Dow index with a 64-cent decline (-0.9%) bringing the stock to $67.08. Volume for E.I. du Pont de Nemours & Company currently sits at 3.4 million shares traded vs. an average daily trading volume of 4.6 million shares.

E.I. du Pont de Nemours & Company has a market cap of $61.3 billion and is part of the basic materials sector and chemicals industry. Shares are up 4.2% year-to-date as of Wednesday's close. The stock's dividend yield sits at 2.7%.

E. I. du Pont de Nemours and Company operates as a science and technology based company worldwide. Its Agriculture segment provides corn hybrid, soybean, canola, sunflower, sorghum, inoculants, wheat, and rice seed products under the Pioneer brand; and herbicides, fungicides, and insecticides.

TheStreet Ratings rates E.I. du Pont de Nemours & Company as a buy. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, revenue growth, solid stock price performance, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
null

If you liked this article you might like

Why Bayer's $66 Billion Takeover of Monsanto Probably Won't Happen Until 2018

DowDupont Closes Higher in First Day of Trading, Company Still Faces Challenges

Apple Is the Tom Brady of Stocks: Cramer's 'Mad Money' Recap (Thursday 8/31/17)

FMC Stock's Impressive Rally Has Another 20% to Gain: Jim Cramer

Jim Cramer on Why FMC Was Upgraded by Bank of America